Effect of prophylactically administered penicillin on incidence of bacteremia following extraction of teeth. Arch Intern Med. 1948;81:868 878. 75. Shanson DC, Akash S, Harris M, Tadayon M. Erythromycin stearate, 1.5 g, for the oral prophylaxis of streptococcal bacteraemia in patients undergoing dental extraction: efficacy and tolerance. J Antimicrob Che- mother. 1985;15:83 90. 76. Roberts GJ, Radford P, Holt R. Prophylaxis of dental bacteraemia with oral amoxycillin in children. Br Dent J. 1987;162:179 182. 77. Hall G, Heimdahl A, Nord CE. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction. Eur J Clin Microbiol Infect Dis. 1995;15:646 649. 78. Hall G, Heimdahl A, Nord CE. Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis. Clin Infect Dis. 1999;29:1 8; quiz 9 10. 79. Macfarlane TW, Ferguson MM, Mulgrew CJ. Post-extraction bacter- aemia: role of antiseptics and antibiotics. Br Dent J. 1984;156:179 181. 80. Oliver R, Roberts GJ, Hooper L. Penicillins for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev. 2004: CD003813. 81. Guntheroth WG. How important are dental procedures as a cause of infective endocarditis? Am J Cardiol. 1984;54:797 801. 82. Everett ED, Hirschmann JV. Transient bacteremia and endocarditis prophylaxis: a review. Medicine (Baltimore). 1977;56:61 77. 83. Horstkotte D, Rosin H, Friedrichs W, Loogen F. Contribution for choosing the optimal prophylaxis of bacterial endocarditis. Eur Heart J. 1987;8(supp J):379 381. 84. Imperiale TF, Horwitz RI. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med. 1990;88:131 136. 85. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemi- ology of bacterial endocarditis in The Netherlands, II: antecedent pro- cedures and use of prophylaxis. Arch Intern Med. 1992;152:1869 1873. 86. Van der Meer JT, Van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet. 1992;339:135 139. 87. van der Meer JT, van Wijk W, Thompson J, Valkenburg HA, Michel MF. Awareness of need and actual use of prophylaxis: lack of patient compliance in the prevention of bacterial endocarditis. J Antimicrob Chemother. 1992;29:187 194. 88. Duval X, Alla F, Hoen B, Danielou F, Larrieu S, Delahaye F, Leport C, Briancon S. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without anti- biotic prophylaxis. Clin Infect Dis. 2006;42:e102 e107. 89. Starkebaum M, Durack D, Beeson P. The incubation period of sub- acute bacterial endocarditis. Yale J Biol Med. 1977;50:49 58. 90. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 1993;7:9 19. 91. Pallasch TJ, Wahl MJ. Focal infection: new age or ancient history? Endodontic Topics. 2003;4:32 45. 92. Idsoe O, Guthe T, Willcox RR, de Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from ana- phylactic shock. Bull World Health Organ. 1968;38:159 188. 93. Ahlstedt S. Penicillin allergy: can the incidence be reduced? Allergy. 1984;39:151 164. 94. Agha Z, Lofgren RP, VanRuiswyk JV. Is antibiotic prophylaxis for bac- terial endocarditis cost-effective? Med Decis Making. 2005;25:308 320. 95. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001;345: 804 809. 96. Guay DR, Patterson DR, Seipman N, Craft JC. Overview of the toler- ability profile of clarithromycin in preclinical and clinical trials. Drug Saf. 1993;8:350 364. 97. Mazur N, Greenberger PA, Regalado J. Clindamycin hypersensitivity appears to be rare. Ann Allergy Asthma Immunol. 1999;82:443 445. 98. Bombassaro AM, Wetmore SJ, John MA. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. J Can Dent Assoc. 2001;67:20 22. 99. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, Moustafa SE, Hoskin TL, Mandrekar JN, Wilson WR, Baddour LM. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005;293:3022 3028. 100. Griffin MR, Wilson WR, Edwards WD, O Fallon WM, Kurland LT. Infective endocarditis: Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985;254:1199 1202. 101. Durack DT, Petersdorf RG. Changes in the epidemiology of endocarditis. Paper presented at: Infective Endocarditis: An American Heart Association Symposium; held May 14 15, 1976. In: AHA Monograph #52, 1977. 102. Delahaye F, Goulet V, Lacassin F, et al. Characteristics of infective endo- carditis in France in 1991: a 1-year survey. Eur Heart J. 1995;16:394 401. 103. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F; Association pour l Etude et la Prevention de l Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75 81. 104. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318 1330. 105. Gersony WM, Hayes CJ, Driscoll DJ, Keane JF, Kidd L, O Fallon WM, Pieroni DR, Wolfe RR, Weidman WH. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(suppl):I-121 I-126. 106. Wilson WR, Jaumin PM, Danielson GK, Giuliani ER, Washington JA II, Geraci JE. Prosthetic valve endocarditis. Ann Intern Med. 1975;82:751 756. 107. Baddour LM, Wilson WR. Infections of prosthetic valves and other cardio- vascular devices. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett s Principles and Practice of Infectious Diseases. Philadelphia, Pa: Elsevier Churchill Livingstone; 2005:1022 1044. 108. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America. Infective endo- carditis: diagnosis, antimicrobial therapy, and management of compli- cations: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Car- diovascular Disease in the Young, and the Councils on Clinical Car- diology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America [published correction appears in Circulation. 2005;112:2373]. Circulation. 2005;111:e394 e434. 109. Wilson WR, Danielson GK, Giuliani ER, Geraci JE. Prosthetic valve endocarditis. Mayo Clin Proc. 1982;57:155 161. 110. Wilson WR, Geraci JE, Wilkowske CJ, Washington JA II. Short-term intramuscular therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans streptococci. Circulation. 1978; 57:1158 1161. 111. Anderson DJ, Olaison L, McDonald JR, Miro JM, Hoen B, Selton-Suty C, Doco-Lecompte T, Abrutyn E, Habib G, Eykyn S, Pappas PA, Fowler VG, Sexton DJ, Almela M, Corey GR, Cabell CH. Enterococcal pros- thetic valve infective endocarditis: report of 45 episodes from the Inter- national Collaboration on Endocarditis-merged database. Eur J Clin Microbiol Infect Dis. 2005;24:665 670. 112. Chu VH, Cabell CH, Abrutyn E, Corey GR, Hoen B, Miro JM, Olaison L, Stryjewski ME, Pappas P, Anstrom KJ, Eykyn S, Habib G, Benito N, Fowler VG Jr; International Collaboration on Endocarditis Merged Database Study Group. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2004;39:1527 1530. 113. Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P, Woods CW, Cabell CH, Hoen B, Selton-Suty C, Doco-Lecompte T, Chirouze C, Raoult D, Miro JM, Mestres CA, Olaison L, Eykyn S, Abrutyn E, Fowler VG Jr; The International Collaboration on Endocarditis Merged Database Study Group. Prosthetic valve endocarditis due to coagulase-negative staph- ylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis. 2006;25:365 368. 114. McDonald JR, Olaison L, Anderson DJ, Hoen B, Miro JM, Eykyn S, Abrutyn E, Fowler VG Jr, Habib G, Selton-Suty C, Pappas PA, Cabell CH, Corey GR, Marco F, Sexton DJ. Enterococcal endocarditis: 107 cases from the International Collaboration on Endocarditis Merged Database. Am J Med. 2005;118:759 766. 115. Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, Dismukes W, Drew RH, Durack DT; Endocarditis Treatment Consortium Group. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Clin Infect Dis. 1998;27:1470 1474. 116. Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks: efficacy and outpatient treatment feasibility. JAMA. 1992; 267:264 267. 117. Wilson WR, Wilkowske CJ, Wright AJ, Sande MA, Geraci JE. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med. 1984;100:816 823. 118. Mansur AJ, Dal Bo CM, Fukushima JT, Issa VS, Grinberg M, Pomer- antzeff PM. Relapses, recurrences, valve replacements, and mortality Wilson et al Prevention of Infective Endocarditis 1753 during the long-term follow-up after infective endocarditis. Am Heart J. 2001;141:78 86. 119. Baddour LM. Twelve-year review of recurrent native-valve infective endocarditis: a disease of the modern antibiotic era. Rev Infect Dis. 1988;10:1163 1170. 120. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, Singh RK, Fowler VG Jr, Corey GR, Aksoy O, Woods CW. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis. 2005;41:406 409. 121. Welton DE, Young JB, Gentry WO, Raizner AE, Alexander JK, Chahine RA, Miller RR. Recurrent infective endocarditis: analysis of predisposing factors and clinical features. Am J Med. 1979;66:932 938. 122. Levison ME, Kaye D, Mandell GL, Hook EW. Characteristics of patients with multiple episodes of bacterial endocarditis. JAMA. 1970; 211:1355 1357. 123. Renzulli A, Carozza A, Romano G, De Feo M, Della Corte A, Gregorio R, Cotrufo M. Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann Thorac Surg. 2001;72:39 43. 124. Erbel R, Liu F, Ge J, Kupferwasser I. Identification of high-risk sub- groups in infective endocarditis and the role of echocardiography. Eur Heart J. 1995;16:588 602. 125. Kaplan EL, Rich H, Gersony W, Manning J. A collaborative study of infective endocarditis in the 1970s: emphasis on infections in patients who have undergone cardiovascular surgery. Circulation. 1979;59:327 335. 126. Coward K, Tucker N, Darville T. Infective endocarditis in Arkansan children from 1990 through 2002. Pediatr Infect Dis J. 2003;22: 1048 1052. 127. Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993;122:847 853. 128. Dodo H, Child JS. Infective endocarditis in congenital heart disease. Cardiol Clin. 1996;14:383 392. 129. Martin JM, Neches WH, Wald ER. Infective endocarditis: 35 years of experience at a children s hospital. Clin Infect Dis. 1997;24:669 675. 130. Parras F, Bouza E, Romero J, Buzon L, Quero M, Brito J, Vellibre D. Infectious endocarditis in children. Pediatr Cardiol. 1990;11:77 81. 131. Takeda S, Nakanishi T, Nakazawa M. A 28-year trend of infective endocarditis associated with congenital heart diseases: a single institute experience. Pediatr Int. 2005;47:392 396. 132. Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, Wilson W, Bolger AF, Bayer A, Levison ME, Pallasch TJ, Gage TW, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association Council on Cardiovascular Disease in the Young. Unique features of infective endocarditis in childhood. Circulation. 2002;105:2115 2126. 133. Ishiwada N, Niwa K, Tateno S, Yoshinaga M, Terai M, Nakazawa M; for The Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Working Groups for Guidelines for Prophylaxis, Diagnosis and Management of Infective Endocarditis in Patients With Congenital Heart Disease. Causative organism influences clinical profile and outcome of infective endocarditis in pediatric patients and adults with congenital heart disease. Circ J. 2005;69:1266 1270. 134. Han YM, Gu X, Titus JL, Rickers C, Bass JL, Urness M, Amplatz K. New self-expanding patent foramen ovale occlusion device. Catheter Cardiovasc Interv. 1999;47:370 376. 135. Prabhu RM, Piper KE, Baddour LM, Steckelberg JM, Wilson WR, Patel R. Antimicrobial susceptibility patterns among viridans group strepto- coccal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother. 2004;48:4463 4465. 136. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother. 1996;40:891 894. 137. Diekema DJ, Beach ML, Pfaller MA, Jones RN; SENTRY Participants Group. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin Microbiol Infect. 2001;7:152 157. 138. Groppo FC, Castro FM, Pacheco AB, Motta RH, Filho TR, Ramacciato JC, Florio FM, Meechan JG. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients. Gen Dent. 2005;53:410 413. 139. Teng LJ, Hsueh PR, Chen YC, Ho SW, Luk KT. Antimicrobial suscep- tibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother. 1998;41:621 627. 140. Tuohy M, Washington JA. Antimicrobial susceptibility of viridans group streptococci. Diagn Microbiol Infect Dis. 1997;29:277 280. 141. Seppala H, Haanpera M, Al-Juhaish M, Jarvinen H, Jalava J, Huovinen P. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Che- mother. 2003;52:636 644. 142. Marron A, Carratala J, Alcaide F, Fernandez-Sevilla A, Gudiol F. High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients. J Antimicrob Che- mother. 2001;47:87 91. 143. Wu JJ, Lin KY, Hsueh PR, Liu JW, Pan HI, Sheu SM. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob Agents Chemother. 1997;41:844 846. 144. King A, Bathgate T, Phillips I. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. Clin Microbiol Infect. 2002;8:85 92. 145. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM, Kaye D. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000; 102:2842 2848. 146. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med. 1999;20:303 316, viii. 147. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, Bland LA, Jarvis WR. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995;172:993 1000. 148. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staph- ylococcus aureus. Arch Intern Med. 1998;158:182 189. 149. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attrib- utable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol. 1999;20:396 401. 150. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bac- teremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26:1127 1133. 151. Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML; for the SENTRY Participants Group. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and anti- microbial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Sur- veillance Program. Diagn Microbiol Infect Dis. 1999;33:283 297. 152. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA; American Heart Association. Nonvalvular cardiovascular device- related infections. Circulation. 2003;108:2015 2031. 153. Sherman-Weber S, Axelrod P, Suh B, Rubin S, Beltramo D, Manacchio J, Furukawa S, Weber T, Eisen H, Samuel R. Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature. Transpl Infect Dis. 2004;6:165 170.